Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by westcoast1000on May 26, 2023 4:19pm
141 Views
Post# 35466475

RE:load up load up

RE:load up load upFormerly, I thought Quentin was a fretful and worried but sincere poster.

Now I think he is a very slick soft basher that is now going harder at it.

He is being quoted on ST or Yahoo (I cannot remember which) as an oracle about the failure of the company. That is a tell from my viewpoint.

If he held lots of shares long term, bashing your own investment, or telling others to trade it, does not enhance the price he can command for his shares. He is undermining his own investment. Why do that? 

He has said the same things over and over: the latest trial was not needed because we could have proceeded five years ago, the CI arm of the trial has failed (there is no evidence of that as yet) etc.

My approach: mute him. 
<< Previous
Bullboard Posts
Next >>